Elevated Intraocular Therapy/Anti-Glaucoma Agents

Question 1

What are elevated intraocular therapy/anti-glaucoma agents indicated for? (2)

Answer 1

• open-angle glaucoma
• ocular hypertension

Question 2

What are elevated intraocular therapy/anti-glaucoma agents contraindicated in?

Answer 2

patients with hypersensitivity

Question 3

What is brimonidine contraindicated in? (2)

Answer 3

• ≤ 2 years old
• patients taking monoamine oxidase inhibitors

Question 4

What is timolol contraindicated in? (6)

Answer 4

• asthma
• severe COPD
• sinus bradycardia
• sick sinus syndrome
• heart block not controlled with a pacemaker
• cardiac failure

Question 5

brimonidine (2)

Answer 5

alpha-2 adrenergic agonist

• Alphagan*
• Alphagan P*

Question 6

Dosage Forms and Strengths

Alphagan (1)

Answer 6

ophthalmic soln: 0.2% w/v brimonidine tartrate

Question 7

Dosage Forms and Strengths

Alphagan P (1)

Answer 7

ophthalmic soln: 0.15% w/v brimonidine tartrate

Question 8

brimonidine / timolol (1)

Answer 8

alpha-2 adrenergic agonist / beta blocker

• Combigan*

Question 9

Dosage Forms and Strengths

Combigan (1)

Answer 9

ophthalmic soln: 0.2% brimonidine tartrate / 0.5% timolol

Question 10

bimatoprost (2)

Answer 10

prostaglandin F2α analogue

• Lumigan RC
• Vistitan

Question 11

Dosage Forms and Strengths

Lumigan RC (1)

Answer 11

opht soln: 0.01% w/v

Question 12

Dosage Forms and Strengths

Vistitan (1)

Answer 12

opht soln: 0.03% w/v

Question 13

timolol (2)

Answer 13

beta blocker

• Timoptic*
• Timoptic-XE* (brand name for 0.25% D/C)

Question 14

Dosage Forms and Strengths

Timoptic (1)

Answer 14

opthalmic soln: 0.5% w/v

Question 15

Dosage Forms and Strengths

Timoptic-XE (1)

Answer 15

ophthalmic soln: 0.25%, 0.5% w/v

Question 16

dorzolamide (1)

Answer 16

carbonic anhydrase inhibitor

• Trusopt*

Question 17

Dosage Forms and Strengths

Trusopt (1)

Answer 17

ophthalmic soln: 2% w/v dorzolamide

Question 18

dorzolamide / timolol (1)

Answer 18

carbonic anhydrase inhibitor / beta blocker

• Cosopt*

Question 19

Dosage Forms and Strengths

Cosopt (1)

Answer 19

ophthalmic soln: 2% w/v dorzolamide, 0.5% w/v timolol

Question 20

latanoprost (2)

Answer 20

prostaglandin F2α analogue

• Xalatan*
• Monoprost

Question 21

Dosage Forms and Strengths

Xalatan (1)

Answer 21

ophthalmic soln: 0.005% w/v latanoprost

Question 22

Dosage Forms and Strengths

Monoprost (1)

Answer 22

preservative-free ophthalmic soln: 0.005% w/v latanoprost

Question 23

latanoprost / timolol (1)

Answer 23

prostaglandin F2α analogue / beta blocker

• Xalacom*

Question 24

Dosage Forms and Strengths

Xalacom (1)

Answer 24

ophthalmic soln: 0.005% w/v latanoprost, 0.5% timolol

Question 25

latanoprostene bunod (1)

Answer 25

prostaglandin F2α analogue

• Vyzulta

Question 26

Dosage Forms and Strengths

Vyzulta (1)

Answer 26

ophthalmic soln: 0.024% w/v

Question 27

travoprost (2)

Answer 27

prostaglandin F2α analogue

• Travatan Z*
• Izba

Question 28

Dosage Forms and Strengths

Travatan Z (1)

Answer 28

ophthalmic soln: 0.004% w/v travoprost

Question 29

Dosage Forms and Strengths

Izba

Answer 29

ophthalmic soln: 0.003% w/v travoprost

Question 30

travoprost / timolol (1)

Answer 30

prostaglandin F2α analogue / beta blocker

• DuoTravPQ*

Question 31

Dosage Forms and Strengths

DuoTravPQ (1)

Answer 31

ophthalmic soln: 0.004% w/v travoprost, 0.5% w/v timolol

Question 32

brinzolamide (1)

Answer 32

carbonic anhydrase inhibitor

• Azopt

Question 33

Dosage Forms and Strengths

Azopt (1)

Answer 33

ophthalmic susp: 1% w/v

Question 34

brinzolamide / brimonidine (1)

Answer 34

carbonic anhydrase inhibitor / alpha-2 adrenergic agonist

• Simbrinza

Question 35

Dosage Forms and Strengths

Simbrinza (1)

Answer 35

ophthalmic susp: 1% w/v brinzolamide, 0.2% brimonidine

Question 36

brinzolamide / timolol (1)

Answer 36

carbonic anhydrase inhibitor / beta blocker

• Azarga

Question 37

Dosage Forms and Strengths

Azarga (1)

Answer 37

ophthalmic susp: 1% w/v brinzolamide, 0.5% timolol